Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment

[1]  L. Bertoletti,et al.  Platelets as Key Factors in Inflammation: Focus on CD40L/CD40 , 2022, Frontiers in Immunology.

[2]  J. Fish,et al.  Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment , 2021, Frontiers in Pharmacology.

[3]  N. Goswami,et al.  Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis , 2021, Journal of clinical medicine.

[4]  T. Jenssen,et al.  Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis , 2021, PloS one.

[5]  B. Kiss,et al.  Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells , 2021, Journal of clinical medicine.

[6]  H. Sayles,et al.  Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis , 2021, Annals of the Rheumatic Diseases.

[7]  C. Prati,et al.  Methotrexate and cardiovascular risk in rheumatic diseases:A comprehensive review , 2021, Expert review of clinical pharmacology.

[8]  Dafeng Yang,et al.  Methotrexate attenuates vascular inflammation through an adenosine-microRNA-dependent pathway , 2021, eLife.

[9]  G. Fu,et al.  Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima , 2021, Cardiovascular Drugs and Therapy.

[10]  ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.

[11]  E. De Robertis,et al.  Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients , 2020, Journal of Infection.

[12]  J. Tao,et al.  Circulating senescent angiogenic T cells are linked with endothelial dysfunction and systemic inflammation in hypertension , 2020, Journal of hypertension.

[13]  H. Heerspink,et al.  Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study) , 2020, Diabetes, obesity & metabolism.

[14]  H. Nie,et al.  Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow , 2019, Journal of Translational Medicine.

[15]  M. Sabatine,et al.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. , 2019, European heart journal.

[16]  M. Manetti,et al.  Angiogenic T cells in primary Sjögren's syndrome: a double-edged sword? , 2019, Clinical and experimental rheumatology.

[17]  U. Müller-Ladner,et al.  A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity , 2019, Science Translational Medicine.

[18]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[19]  G. Valesini,et al.  Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis , 2018, Immunologic Research.

[20]  D. Courvoisier,et al.  Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis , 2018, Arthritis care & research.

[21]  V. Bojinca,et al.  Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases. , 2018, Experimental and therapeutic medicine.

[22]  H. Volk,et al.  Circulating endothelial cells as biomarker for cardiovascular diseases , 2018, Research and practice in thrombosis and haemostasis.

[23]  A. Mangoni,et al.  Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence , 2017, Mediators of inflammation.

[24]  S. Agewall,et al.  Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis , 2017, Arthritis Research & Therapy.

[25]  B. Cosmi,et al.  Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs. , 2017, Thrombosis research.

[26]  X. Bai,et al.  Methotrexate improves perivascular adipose tissue/endothelial dysfunction via activation of AMPK/eNOS pathway. , 2017, Molecular medicine reports.

[27]  J. Miao,et al.  Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus , 2016, Mediators of inflammation.

[28]  L. Caminal-Montero,et al.  Senescent profile of angiogenic T cells from systemic lupus erythematosus patients , 2016, Journal of leukocyte biology.

[29]  T. Huizinga,et al.  Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[30]  R. Gerli,et al.  Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? , 2015, Rheumatology.

[31]  W. Gulliver,et al.  The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis , 2015, Annals of the rheumatic diseases.

[32]  J. Boyle,et al.  Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation , 2014, Annals of the rheumatic diseases.

[33]  D. Francisci,et al.  Potential anti-inflammatory effects of maraviroc in HIV-positive patients: A pilot study of inflammation, endothelial dysfunction, and coagulation markers , 2014, Scandinavian journal of infectious diseases.

[34]  P. López,et al.  Angiogenic T cells are decreased in rheumatoid arthritis patients , 2014, Annals of the rheumatic diseases.

[35]  D. Francisci,et al.  In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients , 2013, Thrombosis and Haemostasis.

[36]  Gary S Collins,et al.  Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 , 2012, BMJ : British Medical Journal.

[37]  L. Jian,et al.  Effects of Xinfeng Capsules on Expression of Platelet Granule Membrane Protein 140 and Platelet Cluster of Differentiation 40 Ligand in Peripheral Blood of Adjuvant Arthritis Rats , 2012, International journal of rheumatology.

[38]  D. Francisci,et al.  Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. , 2011, AIDS patient care and STDs.

[39]  Emanuela Falcinelli,et al.  Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake. , 2011, American journal of physiology. Heart and circulatory physiology.

[40]  G. Kitas,et al.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications , 2011, Rheumatology International.

[41]  L. Boon,et al.  Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. , 2010, Blood.

[42]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[43]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[44]  T. Rabelink,et al.  Inflammation, vascular injury and repair in rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[45]  M. Verhaar,et al.  Endothelial progenitor cell dysfunction in rheumatic disease , 2009, Nature Reviews Rheumatology.

[46]  Ju-Young Kim,et al.  Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.

[47]  P. Gresele,et al.  Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication , 2007, Thrombosis and Haemostasis.

[48]  A. Giordano,et al.  CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients , 2004, Circulation.

[49]  Patrick André,et al.  Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. , 2002, Circulation.

[50]  R. Schaeffer,et al.  Methotrexate Causes Apoptosis in Postmitotic Endothelial Cells , 2000, Biological research for nursing.

[51]  P. Gresele,et al.  Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. , 2009, Thrombosis research.

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..